Amblyomin-X suppress the formation of tumor growth and new blood vessels (angiogenesis) (Carneiro-Lobo et al., 2009); it also inhibits prothrombinase and tenase activities by hydrolyzing host trypsin and plasmin (substrate for trypsin and plasmin) (Branco et al., 2016). Here, PLG is linked to neoplasm.